Product/Composition:- | Recombinant Human Erythropoietin Alfa Injection Generics |
---|---|
Strength:- | 2000 IU,3000 IU,4000 IU,5000 IU,6000 IU,10,000 IU & 40,000 IU |
Form:- | Injection |
Reference Brands:- | Epogen, Procrit(US), Eprex(EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Recombinant Human Erythropoietin Alfa Injection is used to treat anemia in CKD and cancer patients. Marketed as Epogen®, Procrit® (US) and Eprex® (EU), it boosts red blood cell production and reduces transfusion needs in nephrology and oncology care.
Recombinant Human Erythropoietin Alfa Injection is a biologic therapy used to treat anemia associated with chronic kidney disease (CKD), cancer chemotherapy, and HIV treatment. It stimulates red blood cell production, reducing the need for blood transfusions. Commonly marketed as Epogen® and Procrit® in the US, and Eprex® in the EU, Erythropoietin Alfa is a vital medication in nephrology and oncology care. Available in prefilled syringes and vials, it comes in strengths ranging from 2,000 IU to 10,000 IU. Collaborate with WHO-GMP/EU-GMP certified manufacturers to supply high-quality erythropoietin injections for global Pharma B2B markets.
Embrace a platform that empowers you to invest in gold online effortlessly, making the path to financial growth accessible to everyone.
Get access to the finest pharmacy products with a NazarethPharmacy.com. They offer comprehensive worldwide pharmacy services, making them your best choice for online medications